Medical Disorders
Resources
Basic InformationLookupsLatest News
Insurance Often Covers Ivermectin for COVID, Even Though Drug Doesn't WorkCOVID Cases Surge Again in U.S. Nursing HomesCBD and Cannabis Products for Acne, Psoriasis? Buyer Beware, Dermatologists SayCarbon Monoxide Deaths Soar During Power OutagesAHA News: Transplanting Pig Hearts Into Humans Offers Promise – and PerilCOVAX Program Has Now Sent 1 Billion COVID Vaccines to Poorer NationsCOVID Fatigue: Are You Among the 'Vaxxed & Done'?CDC Advises N95s as Best Masks Against CoronavirusYou Don't Have to Be a Smoker to Get Lung CancerSkipping COVID Vaccine in Pregnancy Brings Big Risks to Mothers, BabiesMasks Cut Distance Coronavirus Travels in Half, Study Finds1 in 10 People With COVID Still Infectious After 10 Days: StudyWorried About Omicron? Expert Offers Tips on Going Out SafelySupreme Court Blocks Biden's Vaccine Mandate for Large EmployersCould the 'Mono' Virus Help Trigger Multiple Sclerosis?AHA News: Obesity Harms Brain Health Throughout Life – Yet Scientists Don't Know WhyWhite House May Soon Offer 'High-Quality' Masks to AmericansCOVID Hospitalizations Rising in Kids Too Young for VaccineProgress on Lung Cancer Drives Overall Decline in U.S. Cancer DeathsNearly 600,000 U.S. Kids Had COVID Last WeekWildfires Plus Heat Make Breathing Dangerous in America's WestHow Safe Is a 'Holiday' From Bone-Strengthening Meds?White House to Give Schools 10 Million Free COVID Tests Every MonthBinaxNOW Test Catches COVID Infection in Many People, Study ShowsU.S. May Soon See Sharp Drop in Omicron Cases, Experts SayAs Omicron Rages, How Important Are Case Counts Anymore?Americans Should Avoid Travel to Canada: CDCRed Cross Says U.S. Blood Supply at Dangerously Low LevelPfizer Says Omicron-Specific Vaccine Ready by MarchRain or Shine, Allergies Are Tough. What's the Link to Weather?U.S. Insurers Must Cover 8 COVID At-Home Tests a Month: White HouseU.S. COVID Hospitalizations Pass Last Winter's PeakIn Breakthrough Transplant, Man Receives Genetically Modified Pig HeartExposure to Common Cold Might Help Shield Against COVIDDrug Combo Boosts Outcomes for Advanced MelanomaDo Not Use At-Home COVID Test Swabs in the Throat: FDAEven Symptom-Free, People With Omicron Much More Likely to Spread COVID: StudiesWant to Avoid Glaucoma? Look at What You EatNew Worry: 'Flurona,' When COVID Meets the FluAmid COVID Test Shortages, Price Gouging Is on the RiseNeed an At-Home COVID Test? Here's Help Finding and Using OneKnow Your Thyroid FactsFDA Shortens Time to Booster After Moderna Vaccine to 5 MonthsCOVID Vaccine May Temporarily Add 1 Day to Menstrual Cycle: StudyHospitals Are Rationing COVID Pills, Infusions as Cases RiseBreakthrough COVID Cases Overwhelmingly Mild for Vaccinated People: StudySupreme Court Hears Arguments on Biden's Vaccine Mandate for Big BusinessMore Evidence That State Lotteries Didn't Boost Vaccination RatesWhite House Finalizes Plan to Send Americans Free COVID Rapid TestsModerna CEO Says 4th COVID Dose May Be Needed Next Fall
Questions and AnswersVideosLinksBook Reviews
Related Topics

Cancer
Men's Health
Women's Health

Moderna CEO Says 4th COVID Dose May Be Needed Next Fall

HealthDay News
by Robin Foster
Updated: Jan 7th 2022

new article illustration

FRIDAY, JAN. 6, 2022 (HealthDay News) -- A fourth COVID shot may be needed for most people by next fall because of what will likely be waning immunity, Moderna CEO Stephane Bancel said Thursday.

While the booster that millions of Americans received this past fall should hold strong through this winter's Omicron surge, Bancel said the efficacy of boosters will probably decline over the course of several months, similar to what happened with the first two doses.

“I will be surprised when we get that data in the coming weeks that it’s holding nicely over time — I would expect that it’s not going to hold great,” Bancel said of the booster shots during an interview with Goldman Sachs during its healthcare CEO conference, CNBC reported.

Governments, including the U.K. and South Korea, are already ordering the doses in preparation, he added.

“I still believe we’re going to need boosters in the fall of ’22 and forward,” Bancel said, adding that people who are older or have underlying health conditions might need annual boosters for years to come.

“We have been saying that we believe first this virus is not going away,” Bancel noted. “We’re going to have to live with it.”

Moderna published preliminary data last month that showed its currently authorized 50 microgram booster shot increased the antibodies that block infection from Omicron 37-fold. A 100 microgram booster increased those antibodies 83-fold.

Meanwhile, data from the United Kingdom found that Moderna and Pfizer’s two-dose vaccines are only about 10% effective at preventing symptomatic infection from Omicron 20 weeks after the second dose, CNBC reported.

The same study, published by the U.K. Health Security Agency, found that booster doses are up to 75% effective at preventing symptomatic infection two weeks after receiving the shot.

But the strength of the booster shots starts to wane after about four weeks, the study found. Boosters were 55% to 70% effective at preventing infection at weeks five to nine, and 40% to 50% effective 10 weeks after receiving the shot.

Moderna's vaccine isn't the only one that may entail a fourth dose at some point.

Pfizer CEO Albert Bourla told CNBC last month that people will likely need a fourth dose, and the shot may be needed sooner than expected due to Omicron’s virulence.

Still, Bancel sounded a positive note on Thursday, saying Omicron could accelerate the transition from the acute crisis caused by the coronavirus to a phase where enough people have some level of immunity so that COVID-19 no longer upends daily life.

But, “what is totally impossible to predict, is there a new mutation coming in a day, a week, three months that is worse in terms of severity of disease,” he added. “That’s a piece that we’ll have to just be cautious about.”

More information

Visit the U.S. Centers for Disease Control and Prevention for more on boosters.


SOURCE: CNBC




Facebook

Amazon Smile

 

Children and Adult services are available now with no wait time.  

Please contact HBH at 860-548-0101, option 2.

 


powered by centersite dot net